Home Blog Page 433

Baguio Green Group Announces 2025 Annual Results

Profit surges 72% to HK$97 million
Hits historical high since listing

HONG KONG, March 25, 2026 /PRNewswire/ — Baguio Green Group Limited (”Baguio” or the ”Group”, Stock Code: 01397.HK) is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”).

During the Year, the Group’s revenue amounted to approximately HK$2,424.6 million, representing a decrease of approximately 6.9% as compared to the same period last year. Profit for the Year amounted to approximately HK$97.1 million, representing an increase of approximately 72.0% as compared to the same period last year. The Board recommends the payment of a final dividend for the Year at HK7.0 cents per share.

Business Overview and Prospects
During the Year, revenue from cleaning services as the Group’s core business amounted to approximately HK$1,896.5 million, accounting for approximately 78.2% of the Group’s total revenue. The Group’s cleaning services cover various scenarios, including for Government streets, markets, police stations, fire stations, leisure venues, hospitals and clinics. In addition, the Group provides cleaning services for numerous different places such as universities, large exhibition centers, Hong Kong International Airport, housing estates and private institutions.

During the Year, the Group successfully awarded a 3-year contract from the Marine Department of the Government for approximately HK$150 million for the provision of “Marine Refuse Cleansing and Disposal Services in the Eastern waters of Hong Kong”. This contract marks a significant milestone for Baguio, as it represents a strategic expansion of its service portfolio from land to sea, further strengthening its leading position in Hong Kong’s integrated environmental services market. Under the contract, Baguio delivers comprehensive marine refuse cleansing and ship refuse collection services in the Eastern waters of Hong Kong starting from 1 October 2025 including, but not limited to: Victoria Harbour, Central, Sheung Wan, Causeway Bay, Tsim Sha Tsui, Yau Ma Tei, Cheung Sha Wan, Shau Kei Wan, Kwun Tong, Sai Kung, Tolo Harbour and Tai Po. Winning this contract signifies strong market recognition of Baguio’s outstanding performance over the past 46 years. The Group will seamlessly extend its professional standards and operational efficiency in land-based waste management to the marine environment, striving to safeguard Hong Kong’s valuable marine ecosystem and present a cleaner, more beautiful Victoria Harbour to both residents and tourists.

Waste management and recycling business recorded revenue of approximately HK$277.8 million, accounting for approximately 11.5% of the Group’s total revenue. The gross profit margin of the waste management and recycling business increased from 11.6% for the same period last year to 15.0%, driving the gross profit of this business up by approximately 25.2% to approximately HK$41.9 million, mainly due to the Government’s proactive promotion of recycling and the substantial expansion of the network of recycling spots, including those for food waste, which facilitated public participation and effectively stimulated collection, and the contribution from the green technology business.

The Group continued to provide Government-related waste collection services to five districts, serving a population of approximately 1.6 million.

In terms of recycling, the Group is contracted by the Environmental Protection Department (“EPD”) of the Government to provide collection services for thousands of recycling spots (including plastics, glass bottles, metals, waste paper and food waste) across Hong Kong. During the Year, the Group provided collection services for recycling bins in public places and schools. Baguio also provides collection services for Recycling Stations of “GREEN@COMMUNITY”, recycling stores and smart recycling machines, and other institutions in Hong Kong. In addition, Baguio also provides the Government with glass bottles collection and management services and food waste collection services in several districts in Hong Kong, and is one of the market leaders. In addition, during the Year, the Group was successfully awarded two 35-month contracts from the EPD, with a total value of approximately HK$43 million. During the Year, the Group was responsible for operating the “GREEN@Tai Wo” and “GREEN@Po Lam” recycling stores, and collaborated with nearby buildings, organizations, and community stakeholders to establish and operate fixed and mobile recycling spots for waste collection, provide community recycling support to facilitate citizens, and promote and educate the public on waste sorting and recycling in the community to strengthen citizens’ recycling habits.

As a leading environmental services provider in Hong Kong, the Group provides integrated environmental management solutions including waste management, smart recycling and professional landscaping services to Kai Tak Sports Park, which hosts major sports events and concerts. With excellent environmental protection technologies and experience in operating large-scale international venues, the Group has fully demonstrated its strength in undertaking large-scale international programmes and delivering high-quality services. During the Year, the Group also provided waste recycling services for various Lunar New Year fairs across Hong Kong Island, Kowloon and the New Territories.

Regarding green technology business, the Group won a new contract in relation to the development and supply of a new generation of solar-powered compacting refuse bins to the Government. This innovative product is designed with an auto-sensing inlet and indicator lights, and under its sealed design, it is equipped with devices for ventilation, lighting, and deodorization. Meanwhile, it is equipped with a big data platform and wireless technology to monitor data in real time, enabling effective tracking of the status of waste collection points, strategic deployment of resources, optimization of operational efficiency, and enhanced planning for future initiatives. Furthermore, the solar-powered compacting refuse bins adopt solar panels and rely on renewable energy, which significantly reduces carbon emissions. They can be flexibly deployed in various scenarios, suitable for remote areas where there are no refuse collection points. This product is expected to be gradually launched into the market in 2026.

The Group seizes the opportunity of smart city development and has been committed to expanding its market share of smart recycling in recent years. Currently, Baguio’s smart recycling products, such as smart recycling machines, smart food waste recycling machines, and smart balances, have been deployed in different places across Hong Kong, including Government venues and schools, private housing estates, commercial buildings, theme parks, large-scale exhibition venues, and sports stadiums. These products provide the public with convenient recycling services 24 hours a day and help increase Hong Kong’s overall recycling volume.

In partnership with Jardine Engineering Corporation Limited, the Pilot Biochar Production Plant at the EcoPark in Tuen Mun converts yard waste into high-quality biochar with pyrolysis technology for various applications, the production plant effectively “turns waste into useful resources”.

As for the landscaping business, the Group provides landscaping services for a wide range of clients, including large private residences, Government premises, schools, shopping malls, hotels, Hong Kong Housing Authority, Hospital Authority, Hong Kong Jockey Club, Hong Kong Science Park, the University of Hong Kong, Hong Kong University of Science and Technology, Hong Kong Wetland Park, as well as 33 sports turf venues under the Leisure and Cultural Services Department, etc. During the Year, the Group provided landscaping services for Kai Tak Sports Park, Hong Kong International Airport, Hong Kong-Shenzhen Innovation and Technology Park, Nano Parks, the Tung Chung New Town Extension (West), Hung Shui Kiu/Ha Tsuen New Development Area and the ventilation building at the eastern portal of the Tseung Kwan O – Lam Tin Tunnel.

For pest management business, the Group provided pest management services for venues in the Tsuen Wan District during the Year. In addition, the Group provided pest and rodent control services for hospitals, clinics and the headquarters of the Kowloon East, Kowloon Central and Kowloon West Clusters under the Hospital Authority. The Group also continued to provide termite control and monitoring services for 24 temples under the Chinese Temples Committee.

The Promotion of Recycling and Proper Disposal of Products (Miscellaneous Amendments) Bill 2025 submitted by the Government was passed by the Legislative Council during the Year. This bill establishes a common legal framework for producer responsibility scheme applicable to different products. Under this framework, the Government plans to submit the producer responsibility scheme on plastic beverage containers and beverage cartons in 2026. The scheme encourages citizens to return used containers for recycling to earn rebate, which will help significantly increase the recycling rate. Benefiting from the scheme, Baguio’s recycling volume is expected to be directly driven up, providing attractive returns for the Group’s long-term investments in recycling services and competitive barriers.

The Government is actively developing the Northern Metropolis. Four new development areas include Kwu Tung North/ Fanling North, Hung Shui Kiu/Ha Tsuen, Yuen Long South, and San Tin Technopole are under construction. The Government has resumed more than 400 hectares of private land within these four new development areas, completed land levelling for 80 hectares, and is progressively handing over these lands to relevant departments for building road and railway infrastructure, public and private housing, schools, public markets, ecological conservation, as well as development of innovation and technology industry. The Group believes that this will bring opportunities for many of its core businesses.

Looking forward, the Group will continue to increase the market share of its core businesses and proactively engage in expansion in Hong Kong and beyond. Meanwhile, in line with the development of the Group, it will actively explore potential mergers and acquisitions, joint ventures or new business projects to accelerate future business growth and deliver substantial and long-term returns to shareholders.

For details of the Group’s 2025 annual results announcement, please visit the following website:
https://www.baguio.com.hk/en/investor/notices/

About Baguio Green Group
Established in 1980, Baguio Green Group (Stock code: 01397.HK) is one of Hong Kong’s largest integrated environmental management solution providers. It provides a full spectrum of professional services including professional cleaning, waste collection & recycling, waste management, green technology, green products, horticulture & landscaping, and pest control. The Group delivers innovative environmental solutions using the latest technologies to serve a wide range of customers in various sectors including Government departments, statutory organizations and multinational corporations. Fully committed to ESG, the Group works relentlessly to advance sustainable development and create a cleaner, greener, healthier city for a greener tomorrow.

Akeso Advances “IO 2.0 + ADC 2.0” Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab

HONG KONG, March 25, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK)  (“Akeso” or the “Company”) announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) to initiate Phase II clinical trials for AK146D1, a first-in-class Trop2 /Nectin4 bispecific antibody-drug conjugate (ADC), and AK138D1, an innovative HER3-targeting ADC.

The studies will evaluate these two novel ADC candidates in combination with the Company’s pioneering immuno-oncology (IO) 2.0 bispecific antibodies, cadonilimab (PD-1/CTLA-4) and ivonescimab (PD-1/VEGF), as well as other proprietary high-potential anti-tumor assets, including AK117 (anti-CD47 monoclonal antibody) and AK109 (anti-VEGF monoclonal antibody), across a spectrum of advanced solid tumors. This milestone marks a strategic acceleration of Akeso’s proprietary “IO 2.0 + ADC 2.0” combination platform into mid-stage clinical development.

These Phase II studies will leverage the cadonilimab and ivonescimab as foundational backbone therapies, capitalizing on their validated clinical profiles in checkpoint blockades and dual VEGF/PD-1 inhibition. The regimens center on Akeso’s internally discovered next-generation ADCs while exploring synergies with the company’s broader internal portfolio.

The convergence of immuno-oncology and ADC modalities has emerged as a high-conviction frontier in oncology therapy, offering the potential to overcome the limitations of monotherapy approaches – such as antigen escape, heterogeneous expression, and narrow therapeutic indices. Akeso holds a distinct global competitive advantage as the only company with two approved cancer immunotherapy checkpoint bispecific antibodies. By pairing these IO backbones with next-generation ADC candidates like AK146D1 and AK138D1, the Company is driving the next generation of combination therapy. AK146D1 and AK138D1 have been specifically designed to expand the therapeutic window and mitigate safety-related limitations of traditional ADCs. The progression of these “IO 2.0 + ADC 2.0” combinations into Phase II development is a significant step in establishing Akeso’s next-generation leadership in the global oncology landscape.

AK146D1 is a first-in-class bispecific ADC engineered to simultaneously target Trop2 and Nectin4, antigens that are frequently co-expressed in epithelial-derived malignancies such as lung, breast, and bladder cancers. This dual-targeting approach is designed to enhance selectivity, address tumor heterogeneity, and overcome the resistance mechanisms common in single-target ADC therapies. AK138D1 is a next-generation ADC targeting HER3, a receptor associated with tumor progression and resistance to established EGFR and HER2 treatments in various malignancies, including ovarian, colorectal, melanoma, and prostate cancers. Early-stage data for both AK146D1 and AK138D1 have demonstrated potent anti-tumor activity and a highly manageable safety profile.

Akeso continues to extend its global IO 2.0 leadership into broader, high-impact combination strategies. Beyond the “IO 2.0 + ADC 2.0” portfolio, the Company is advancing a comprehensive portfolio of novel combination approaches aimed at addressing major unmet clinical needs. These include IO 2.0 combinations with other immune checkpoint inhibitors (ICIs), mRNA-based personalized cancer vaccines (such as AK154), DNA-based therapeutics, and additional novel therapeutic platforms. 

This milestone underscores Akeso’s disciplined execution in translating proprietary platform synergies into clinical progress, positioning the Company at the forefront of next-generation global oncology innovation.

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its proprietary Tetrabody multi-specific antibody platform, Dual-Shield Antibody-Drug Conjugates (ADCs), Dual-Lock T-cell engager (TCE), Tissue-Smart siRNA, Cell Therapies, and Flex-Nano mRNA platforms. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 27 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

Forward-Looking Statements

This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson’s Disease

BEIJING, March 25, 2026 /PRNewswire/ — A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic efficacy in Parkinson’s disease (PD) by remodeling the SPARK circuit. (https://www.nature.com/articles/s41593-026-02228-w)

The findings build directly on the team’s previous identification of a core cortico-subcortical PD circuit derived from the somato-cognitive action network (SCAN), the SPARK (SCAN-Parkinson’s) circuit, as reported in their study published in Nature in February 2026 (https://doi.org/10.1038/s41586-025-10059-1), which first characterized this circuit in PD. These results provide mechanistic evidence that neuromodulation therapies exert their effects through modulation of this circuit, and offer a circuit-level framework for the development of personalized, non-invasive precision treatment strategies.


This study establishes the world’s largest longitudinal DBS-fMRI dataset to date, derived from a systematic one-year follow-up of 14 PD patients. With over 200 hours of high-quality imaging data collected, the research team successfully provides mechanistic insights into how DBS exerts its effects by modulating the SPARK circuit, yielding two key findings:

First, the study reveals that the SPARK circuit is the critical response region for DBS neuromodulation. The research provides powerful evidence that the SPARK circuit is not only the pathological origin of PD but also the core target through which neuromodulation exerts its effects.

Second, the study confirms that DBS remodels abnormal functional connectivity within the SPARK circuit. These results are highly consistent with the team’s previous research published in Nature, proving that the clinical efficacy of DBS essentially stems from the long-term regulation and functional remodeling of abnormal SPARK connectivity.

These findings imply that non-invasive interventions targeting the SPARK circuit are supported by the same biological foundation as surgical neuromodulation.

Furthermore, the research revealed significant individual variability in brain functional networks across patients, which directly influence the clinical outcomes of neuromodulation therapies. This discovery points toward a new direction for the field: a paradigm shift from traditional, empirical “trial-and-error” parameter tuning toward a personalized precision treatment model rooted in individual brain circuits.

Leveraging its proprietary Personalized Brain Functional Sectors (pBFS) technology and a specialized precision circuit stimulation system, Galaxy Brain Scientific has achieved the clinical application of personalized, non-invasive precision intervention. This approach enables a “one-person-one-strategy” model for individualized care. Clinical trials have confirmed that by using the precision circuit stimulation system to deliver non-invasive intervention to each patient’s unique SPARK target, clinical efficacy is more than double that of traditional stimulation targets.

Galaxy Brain Scientific is already moving to bring these insights to the clinical frontline, having begun a pivotal registration trial for Class III devices dedicated to treating PD. “Our goal is to redefine the treatment paradigm for brain disorders,” added Prof. Liu. “By moving from ‘one-size-fits-all’ to ‘one-person-one-strategy’, we are now pioneering the application of this technology to treat complex conditions beyond Parkinson’s, including autism and Alzheimer’s disease.”

About Galaxy Brain Scientific

Galaxy Brain Scientific (https://www.gb-scientific.cn) is a world-leading platform for the translation and industrialization of brain science research. Guided by its mission to “Advancing brain cognition and conquering brain diseases”, the company provides safe, non-invasive, and personalized precision treatment solutions for major brain disorders such as Parkinson’s disease, Alzheimer’s disease, and autism, striving to become a leader in the global field of brain disease diagnosis and treatment.

Man Arrested for Murder, Dismemberment of Lao Woman in Thailand

A Lao man was arrested at the Nong Khai border checkpoint on 24 March after human remains were found in black bags along a canal in Nonthaburi, Thailand.

A Lao national has been arrested at the Nong Khai border checkpoint while allegedly attempting to flee to Laos, after the dismembered remains of a Lao woman were found in black bags along a canal in Pak Kret, Nonthaburi Province, on 24 March.

At around 8 pm, Pak Kret police responded to a report of a suspicious bag containing human remains near a school entrance in Pak Kret district. Forensic officers searched the area and recovered multiple bags containing body parts scattered along the canal bank and in nearby bushes.

A joint investigation between Pak Kret and Thung Song Hong police stations identified a suspect and established the likely scene of the crime as an apartment in the Thung Song Hong area of Bangkok.

The Arrest

Officials arrested the suspect, a 26-year-old Lao national, the same evening at the Nong Khai border checkpoint while attempting to cross into Laos.

Nong Khai immigration officers, acting on intelligence from the Thung Song Hong investigative team, had been coordinating with local security agencies before making the arrest.

During preliminary questioning, the suspect denied killing the victim. Police say he admitted to dismembering her body and disposing of the remains. He faces charges of intentional murder and concealing or destroying a corpse to conceal a death or its cause.

The Investigation

The authorities haven’t formally identified the 20-year-old victim yet pending forensic confirmation. Search teams are continuing to recover remains from the area. Investigators are reviewing CCTV footage.

Authorities say an official statement on the progress of the case will be released in due course.

Money talks: investor turnout to set record

BEIJING, March 25, 2026 /PRNewswire/ — This is a news report from China Daily: 

The 2026 ZGC International Technology Trade Fair is set to open on Wednesday afternoon, poised to achieve its highest-ever investor turnout.

A staff member of iFlytek introduces a pair of artificial intelligence glasses to journalists at a booth in the ZGC International Technology Trade Center.
A staff member of iFlytek introduces a pair of artificial intelligence glasses to journalists at a booth in the ZGC International Technology Trade Center.

As it drives the development of a global “buy and sell” technology network, this year’s fair will anchor itself in global sci-tech trends and ground itself in Beijing’s strategic positioning and key industrial layout, holding more than 20 transaction and matchmaking events. Over 500 technology projects from across China and abroad will be presented, with registered investment institutions reaching a historic high, organizers said.

Following the “1+8+N” framework, the fair comprises one opening ceremony, eight signature events and multiple satellite sessions.

The opening ceremony will bring together a range of guests from global and domestic innovation hubs, including the Beijing-Tianjin-Hebei region, the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area.

Attendees will include scientific research teams, tech companies, industry leaders, technology transfer service platforms, venture capital institutions and science and technology parks. The event will feature the collective signing of a series of projects spanning technology transfer, investment and financing and ecosystem cooperation, alongside the release of talent development policies for the sci-tech service sector and the launch of the “blue vest” technology manager program.

The fair aims to strengthen the interconnection of global innovation resources, building a worldwide technology transaction network. It will deepen cross-border cooperation by hosting dedicated sessions for five key countries, including Switzerland and the United Kingdom, gathering technology managers and over 100 international guests to advance cross-border technology transfer. In upgrading regional collaboration, the fair will gather over 70 regional technological achievements through the Beijing-Tianjin-Hebei tech transfer and matchmaking event. It will establish a “patient capital + scenario-driven” model and work with the Yangtze River Delta and the GBA to build an ecosystem for tech commercialization.

Eight signature events are to be held during the fair, including a forum on technology transfer with 50 participants; the annual meeting of a global technology manager network; a matchmaking conference for integrated innovation among enterprises of all sizes; dedicated sessions on technology transfer from universities and research institutes; a technology matchmaking session focusing on selected key countries; a conference on Beijing-Tianjin-Hebei technology transactions; a special session on major scientific achievements; and a district chiefs’ dialogue session.

New on-site service formats will be introduced, such as a technology transaction “consultation room”, the “blue vest” technology managers, the “achievement store” and a livestreaming channel for sci-tech transformation.

Compared with previous sessions, this year’s fair will be more professional, far-reaching and impactful. Guided by industrial needs, it focuses on cutting-edge fields such as artificial intelligence, embodied AI and life sciences, and taps into high-value resources such as national key labs and regional transfer centers.

“The fair will further highlight its role as an ‘accelerator’ and a ‘bridge for connectivity’ through prominent activities and innovative initiatives, creating a technology exchange event focused on ‘buying globally, selling globally’ and advancing international scientific collaboration as well as technology commercialization,” said an official from the Beijing Science and Technology Commission and Administrative Commission of Zhongguancun Science Park.

The ZGC International Technology Trade Fair, an integral part of the Zhongguancun Forum, was first held in 2020. Focused on buying globally and selling globally, it aims to create a Beijing-based platform for global communication and cooperation, showcasing cutting-edge sci-tech achievements, and hosting supply-demand matchmaking, exchanges and negotiations. It is committed to building a technology transaction ecosystem and growing into a globally influential hub for technology transfer and trade.

The ZGC International Technology Trade Center, the venue for this year’s fair, officially commenced operations on March 16. Jointly established by the Beijing Science and Technology Commission and Administrative Commission of Zhongguancun Science Park and other partners, the center offers a “full-chain, one-stop” integrated service system. This covers project aggregation, exhibition and road shows, technology assessment, transactions, scenario matching and venture capital. It has attracted more than 90 domestic and international institutions, providing support for the fair.

From BFA to the World: M&G Marks 20 Years of Telling China’s Stationery Story

BOAO, China, March 25, 2026 /PRNewswire/ — The Boao Forum for Asia Annual Conference 2026 (BFA) opened on March 24 in Hainan, China under the theme “Shaping a Shared Future: New Dynamics, New Opportunities, New Cooperation.” As the forum’s designated stationery supplier, Shanghai M&G Stationery Inc. (M&G, stock symbol 603899) has supported the event for more than 20 years since 2005, consistently supplying professional, high-quality products. M&G President Chen Huxiong has again been invited to attend, joining government and business leaders from across Asia and beyond.


This year, M&G introduced a co-branded collection created in collaboration with internationally recognized artist Florence Bamberger. Drawing on cosmic themes, the collection features celestial design elements across a full range of products, including writing instruments, notebooks, pencil cases, and backpacks. The premium stationery set allows attendees to experience the craftsmanship and expertise of China’s leading stationery brand.

Aligned with the forum’s sustainability focus, M&G debuted its Eco+Office low-carbon office series at the event. Designed for workplace use, the collection incorporates recycled plastics to reduce emissions at the source. Emissions data is calculated in accordance with ISO 14067 international standards and verified through full lifecycle carbon footprint assessments. M&G encourages more environmentally responsible choices through everyday office products.

As the first publicly listed company in China’s stationery sector to publish an ESG report, M&G continues to expand its sustainability initiatives and it has received a “B” score from the 2025 CDP for climate change. M&G was also included in S&P Global’s Sustainability Yearbook 2026, becoming the only mainland China-based company selected for this recognition.

With more than 30 years in the stationery industry, M&G invests over RMB 100 million annually in research and development and holds more than 1,400 patents. Its products have earned awards from leading international industrial design competitions. As one of the world’s largest stationery manufacturers, M&G has been included in the World Brand Lab’s “China’s 500 Most Valuable Brands” for eight consecutive years, with a brand value of RMB 25.655 billion.

From BFA to markets worldwide, M&G products are sold in more than 100 countries and regions, supported by nearly 70,000 retail outlets across China. The company continues to expand its international presence.

Hitem3D Integrates with OpenClaw Agent Workflows Through Skill-Based API Orchestration

SINGAPORE, March 25, 2026 /PRNewswire/ — Math Magic announced that Hitem3D has been integrated into OpenClaw as a Skill-based API service, allowing agents to execute image-to-3D generation through structured, multi-step workflows. The integration introduces a programmable execution model where 3D generation is handled through defined API calls rather than manual interaction.

From Prompting to Structured Execution

Within the OpenClaw environment, generation is no longer treated as a single-step action but as a sequence of coordinated operations. Agents identify task intent—such as converting a single image, processing multiple views, or generating portrait models—then confirm parameters including resolution, output format, and generation mode before submitting jobs via API.

The system handles asynchronous execution by polling job status and returning result links alongside parameter summaries. This structured orchestration improves reproducibility and enables developers to embed 3D generation into larger automated pipelines.

Controlling Inputs, Outputs, and Workflow Behavior

By exposing generation through Skill-based APIs, the workflow provides clearer control over how inputs are processed and outputs are generated, supporting formats such as STL for 3D printing and GLB for real-time use, with adjustable resolution tiers and generation modes.

Technically, the platform integrates geometry and texture generation within a unified workflow designed to improve surface consistency and downstream compatibility, reducing visible seams and avoiding common texture-related issues, particularly in occluded regions.


Supporting Production-Oriented Pipelines

Hitem3D supports high-resolution 1536³ internal texture representation and is designed to reduce isolated or unsupported mesh elements, improving reliability in downstream workflows. Outputs are compatible with common slicing software, where models can be further prepared using standard repair tools before printing. Wall thickness can be adjusted to support typical FDM and resin workflows.

“Structured API orchestration allows developers to define not just what is generated, but how it is generated,” said a Math Magic representative.

Developers interested in implementing this workflow can access the Skill and API integration details at: https://clawhub.ai/lihuihui-bj/hitem3d.

Hitem3D v2.0 is now available worldwide. Learn more about Hitem3D v2.0 and explore sample outputs at hitem3d.ai and hitem3d.ai/3dprinting/use-case.

About Hitem3D
Hitem3D, pioneered by Math Magic (founded 2024), converts single or multi-view images into production-ready 3D models for 3D printing, industrial design, and game asset creation. The platform serves users in more than 150 countries and integrates into professional digital production workflows.

Website: https://www.hitem3d.ai/ 

CDNetworks Urges Enterprises to Shift Away from Single-Provider Risk with New Buyer’s Guide

SINGAPORE, March 25, 2026 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, today released Breaking Single-Provider Dependency and Strengthening Platform Resilience, a new buyer’s guide urging enterprises to reduce single-provider risk by evaluating secondary providers and strengthening service continuity.

Despite growing digital complexity, many organizations still rely on a single provider to power and protect their applications. When outages, performance issues, or unexpected infrastructure changes occur, reliance on a single provider can quickly create a single point of failure, affecting everything from customer experience to revenue.

Introducing a secondary provider offers a more resilient approach, allowing organizations to reroute traffic in real time and keep services available when primary networks falter. However, in a crowded market with overlapping capabilities, identifying the right partner remains a challenge.

A Practical Tool for Evaluation

CDNetworks’ newly released guide is designed to cut through the complexity. It empowers businesses to confidently evaluate secondary delivery platforms and move from consideration to implementation.

Key sections include:

  • Four risks associated with relying on a single delivery provider
  • Essential criteria for evaluating secondary platforms
  • A practical checklist to guide vendor assessment and selection
  • A comparison of CDNetworks with other leading cloud providers

“A string of high-profile outages across major cloud platforms in late 2025 has brought renewed attention to the importance of operational control,” said Antony Li, APAC Head of Sales at CDNetworks. “Enterprises that wait until after an incident to evaluate alternatives are already behind. With this guide, we want to help organizations take a more proactive approach to resilience by evaluating secondary providers before disruptions occur.”

Access the Full Guide

Breaking Single-Provider Dependency and Strengthening Platform Resilience is now available. Download the full guide.

About CDNetworks

As the APAC-leading network with over 2,800 global Points of Presence and more than 20 years of technology experience, CDNetworks delivers the fastest and most secure digital experiences to end users. Our diverse products and services include web performancemedia deliverycloud securityedge computingzero-trust security, and colocation services — all designed to spur business innovation.

To learn more, visit cdnetworks.com and follow us on LinkedIn.